S
Stockadora

Recent Material Events

Track the latest material events (8-K filings) with AI-powered analysis. Stay informed about major corporate developments, acquisitions, and changes.

📊 1175 Events
🤖 AI Analyzed
Recent
📄 Page 48 of 98
Mereo BioPharma Group plc
8-K January 12, 2026

Key Highlights

  • Mereo BioPharma has a cash runway extending until mid-2027, providing a solid ti...
  • The company had approximately $41 million in cash and cash equivalents as of Dec...
  • This financial stability allows the company to continue research and development...
Read Analysis
🤖 AI Generated
BioXcel Therapeutics, Inc.
8-K January 12, 2026

Key Highlights

  • BioXcel Therapeutics is launching a new commercial push for IGALMI™ for potentia...
  • Mark Pavao has been hired as Interim Chief Commercial Officer to lead the at-hom...
  • A supplemental New Drug Application (sNDA) for at-home use of IGALMI™ in bipolar...
Read Analysis
🤖 AI Generated
Quantum Computing Inc.
8-K January 12, 2026

Key Highlights

  • Strategic expansion into the high-growth LiDAR market for vehicles.
  • Potential diversification beyond core quantum computing business.
  • Opportunity to acquire established technology, patents, and equipment.
Read Analysis
🤖 AI Generated
Luminar Technologies, Inc./DE
8-K January 12, 2026

Key Highlights

  • Luminar Technologies, Inc./DE has filed for Chapter 11 bankruptcy, indicating de...
  • The company's stock has been delisted from Nasdaq and now trades on the less reg...
  • Luminar has agreed to sell a significant part of its core LiDAR business assets ...
Read Analysis
🤖 AI Generated
Assertio Holdings, Inc.
8-K January 12, 2026

Key Highlights

  • Assertio Holdings, Inc. has officially regained compliance with Nasdaq's minimum...
  • The significant risk of delisting from the Nasdaq exchange has been removed.
  • This signals a level of stability and reassures investors that the company meets...
Read Analysis
🤖 AI Generated
Orchestra BioMed Holdings, Inc.
8-K January 12, 2026

Key Highlights

  • Orchestra BioMed is set to receive up to $21 million from the Vivasure acquisiti...
  • A significant cash injection of $11 million is expected in 2026, with $5 million...
  • The event validates Orchestra BioMed's business model of 'risk-reward sharing pa...
Read Analysis
🤖 AI Generated
GENESCO INC
8-K January 12, 2026

Key Highlights

  • GENESCO INC announced early comparable sales numbers for its fourth fiscal quart...
  • The company is presenting these results at the 2026 ICR Conference, indicating p...
  • Comparable sales are highlighted as a crucial indicator of the company's retail ...
Read Analysis
🤖 AI Generated
Direct Digital Holdings, Inc.
8-K January 12, 2026

Key Highlights

  • Ensures Nasdaq listing, vital for visibility and liquidity.
  • Boosts stock price per share, improving market perception and making it look mor...
  • Helps meet minimum price requirements to stay listed on the Nasdaq stock exchang...
Read Analysis
🤖 AI Generated
Pelthos Therapeutics Inc.
8-K January 12, 2026

Key Highlights

  • Pelthos adjusted director compensation to align with peer group standards.
  • The changes aim to attract and retain highly skilled and engaged non-employee di...
  • The company clarified that there will be no annual equity grants, helping manage...
Read Analysis
🤖 AI Generated
ASP Isotopes Inc.
8-K January 12, 2026

Key Highlights

  • Official closure of the major acquisition of Renergen Limited, expanding into he...
  • Strategic diversification of ASP Isotopes' business beyond isotopes into energy ...
  • Integration of key Renergen leaders, Stefano Marani (President, Electronics and ...
Read Analysis
🤖 AI Generated
RenX Enterprises Corp.
8-K January 12, 2026

Key Highlights

  • Conditional debt reduction of $5.0 million, reducing immediate debt burden.
  • Potential future upside: RenX could receive 70% of profits if the Lago Vista pro...
  • A necessary step towards managing debt and achieving financial stability.
Read Analysis
🤖 AI Generated
Venture Global, Inc.
8-K January 12, 2026

Key Highlights

  • Plaquemines facility demonstrates strong performance with a high average liquefa...
  • Company utilized its own fleet to navigate shipping challenges, ensuring continu...
  • Anticipated improvement in shipping conditions in early 2026.
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from material event filings with our AI-powered analysis. Track corporate developments, acquisitions, and strategic changes.

Back to Homepage